Markers in Cardiology
A Case-Oriented Approach
Autor*innen
Mehr zum Buch
With the rapid development of the field of cardiac biomarkers comes a need for updated guidance on how to use them clinically. Drs. Adams, Jaffe, and Apple meet that need with this timely reference.Taking a case-oriented approach for the greatest clinical relevance, the book bridges the gap between science and practice. If you use – or want to use – cardiac markers such as BNP and troponin to help your patients, you will find this clear and comprehensive reference provides a dependable source of valuable information.The 19 chapters are divided into three parts:• Cardiac Troponins• Natriuretic Peptides• Contemporary Markers of RiskThe authors cover the technical, clinical, and outcome assessments for each marker used in clinical practice. After each case scenario, an extensive discussion explains the clinical decisions and provides valuable context.
Buchkauf
Markers in Cardiology, Jesse E. Adams, Allan S. Jaffe, Fred S. Apple
- Sprache
- Erscheinungsdatum
- 2007
- Einband
- (Hardcover),
- Buchzustand
- Gebraucht - Sehr gut
- Preis
- € 62,39
Keiner hat bisher bewertet.
- Titel
- Markers in Cardiology
- Untertitel
- A Case-Oriented Approach
- Sprache
- Englisch
- Autor*innen
- Jesse E. Adams, Allan S. Jaffe, Fred S. Apple
- Verlag
- Wiley-Blackwell
- Erscheinungsdatum
- 2007
- Einband
- Hardcover
- Seitenzahl
- 272
- ISBN10
- 1405134186
- ISBN13
- 9781405134187
- Reihe
- Schlagwörter
- Medizin
- Beschreibung
- With the rapid development of the field of cardiac biomarkers comes a need for updated guidance on how to use them clinically. Drs. Adams, Jaffe, and Apple meet that need with this timely reference.Taking a case-oriented approach for the greatest clinical relevance, the book bridges the gap between science and practice. If you use – or want to use – cardiac markers such as BNP and troponin to help your patients, you will find this clear and comprehensive reference provides a dependable source of valuable information.The 19 chapters are divided into three parts:• Cardiac Troponins• Natriuretic Peptides• Contemporary Markers of RiskThe authors cover the technical, clinical, and outcome assessments for each marker used in clinical practice. After each case scenario, an extensive discussion explains the clinical decisions and provides valuable context.